Using ACE2 structure to predict SARS-CoV-2 susceptibility in animals

NewsGuard 100/100 Score

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which caused the coronavirus disease 2019 (COVID-19) pandemic, gains entry to the host cell by binding to the angiotensin-converting enzyme 2 (ACE2). COVID-19 has repeatedly demonstrated its ability to infect an increasing number of mammalian species, such as tigers, mink, white-tailed deer, and many more.

Researchers based at the Rice University, Texas, USA, have now demonstrated a novel method of predicting a species' susceptibility to contracting COVID-19, based on the animal's structure of ACE2.

A pre-print version of the research paper is available to read in full on the bioRxiv*server.

What was the study

SARS-CoV-2 has always been presumed to have a zoonotic origin, either arising from bat or pangolin coronaviruses. While it is still unknown exactly which of these it first spread from, its ability for cross-species transmission is what has allowed the global COVID-19 pandemic to ensue, after being passed to humans at some point in late 2019.

Since the identification of the virus, multiple reported cases of COVID-19 have been confirmed in a number of domestic and wild mammal species. This has raised concerns that cross-species transmissibility may result in both local ecological outbreaks, but also that infected animals may re-transmit the virus back onto humans.

Previous research has suggested that pangolin coronaviruses were more likely to have been the ancestral virus for SARS-CoV-2, as pangolin ACE2 receptors in host cells to which the virus binds to are similar in both humans and pangolins. Additionally, experimental infection of white-tailed deer, which also share a similar ACE2 structure, have shown susceptibility to the disease.

Dr. Ryan Cheng and colleagues of the Rice University set out to therefore experimentally predict species that may be at risk of contracting COVID-19, based on the protein sequence of ACE2, to establish a theoretical list of species potentially at-risk to the virus.

The study

ACE2 topology is widely variable amongst mammal species, and frequently many species distantly related may share ACE2 receptors with very similar appearances.

Cheng and colleagues examined a selection of ACE2 topologies from 63 animals and assessed the potential of each of these to allow the SARS-CoV-2 virus to bind. To do this, they used the "energetic frustration" concept, a part of protein folding theory, as a proxy for binding affinity.

Essentially, the more dissimilar a protein receptor is to a subject trying to enter it, the more energy will be expelled as that subject attempts to bind. Therefore, a foreign protein or virus subject may be prevented from cell entry through a "kinetic trap," as it would take more energy to enter the cell than it can expend. More significant energetic frustration, therefore, represents lower ACE2 binding affinity, whilst minimal frustration represents higher affinity, allowing COVID-19 to enter a host cell.

Using human ACE2 as a template, an energy-landscape analysis was conducted on the models of the animal ACE2, measuring how favorable each receptor was to COVID-19 spike binding.

Phylogenic tree representing the evolutionary distance between ACE2 proteins of different species. The lengths in the radial direction denote the Jukes-Cantor distance as a measure of evolutionary distance between any two ACE2 proteins. The experimental observation of SARS-CoV-2 resistance/susceptibility are plotted alongside the computational predictions for resistance/susceptibility based on our frustration analysis of the a consistency between the computational predictions and the experimental observations for mouse (Mus musculus), chicken (Gallus gallus domesticus), duck (Anas platyrhynchos), mink (Neovison vison), bat (Eidolon helvum), Syrian golden hamster (Mesocricetus auratus), tiger (Panthera tigris), white-tailed deer (Odocoileus virginianus), European rabbit (Oryctolagus cuniculus), and pig (Sus scrofa). However, apparent inconsistencies are found for ferret (Mustela putorius furo) and dog (Canis lupis familiaris) —however, SARS-Cov-2 has only been observed to replicate in the upper respiratory tract of ferrets, and viral replication has been observed to be low in dogs.
Phylogenic tree representing the evolutionary distance between ACE2 proteins of different species. The lengths in the radial direction denote the Jukes-Cantor distance as a measure of evolutionary distance between any two ACE2 proteins. The experimental observation of SARS-CoV-2 resistance/susceptibility are plotted alongside the computational predictions for resistance/susceptibility based on our frustration analysis of the a consistency between the computational predictions and the experimental observations for mouse (Mus musculus), chicken (Gallus gallus domesticus), duck (Anas platyrhynchos), mink (Neovison vison), bat (Eidolon helvum), Syrian golden hamster (Mesocricetus auratus), tiger (Panthera tigris), white-tailed deer (Odocoileus virginianus), European rabbit (Oryctolagus cuniculus), and pig (Sus scrofa). However, apparent inconsistencies are found for ferret (Mustela putorius furo) and dog (Canis lupis familiaris) —however, SARS-Cov-2 has only been observed to replicate in the upper respiratory tract of ferrets, and viral replication has been observed to be low in dogs.

What the study found

The researchers' findings suggest high susceptibility to SARS-CoV-2 infection for 16 of the 63 animals, with moderate susceptibility for a further 14. The remaining animals were predicted to have resistance to virus binding.

These findings corroborate well with experimental observations of SARS-CoV-2 infection in some of the animal species, however, with two exceptions: ferrets and dogs. The authors provide a plausible explanation for this:

"SARS-CoV-2 has only been observed to replicate in the upper respiratory tract of ferrets, and viral replication has been observed to be low in dogs."

Concluding remarks

The study's authors have demonstrated a potentially powerful tool for indicating species that may be at risk from SARS-CoV-2. Whilst right now the researchers only analyzed potential susceptibility through ACE2 – there are many more potential determinants at play most likely – it represents how an energy landscape-based analysis can be used to assess the interactions of ACE2 and SARS-CoV-2.

Important notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Michael Burgess

Written by

Michael Burgess

Michael graduated with a first-class degree in Zoology from the University of Hull, and later received a Masters degree in Palaeobiology from the University of Bristol.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Burgess, Michael. (2021, March 30). Using ACE2 structure to predict SARS-CoV-2 susceptibility in animals. News-Medical. Retrieved on April 24, 2024 from https://www.news-medical.net/news/20210330/Using-ACE2-structure-to-predict-SARS-CoV-2-susceptibility-in-animals.aspx.

  • MLA

    Burgess, Michael. "Using ACE2 structure to predict SARS-CoV-2 susceptibility in animals". News-Medical. 24 April 2024. <https://www.news-medical.net/news/20210330/Using-ACE2-structure-to-predict-SARS-CoV-2-susceptibility-in-animals.aspx>.

  • Chicago

    Burgess, Michael. "Using ACE2 structure to predict SARS-CoV-2 susceptibility in animals". News-Medical. https://www.news-medical.net/news/20210330/Using-ACE2-structure-to-predict-SARS-CoV-2-susceptibility-in-animals.aspx. (accessed April 24, 2024).

  • Harvard

    Burgess, Michael. 2021. Using ACE2 structure to predict SARS-CoV-2 susceptibility in animals. News-Medical, viewed 24 April 2024, https://www.news-medical.net/news/20210330/Using-ACE2-structure-to-predict-SARS-CoV-2-susceptibility-in-animals.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research highlights emergence of immune-evasive SARS-CoV-2 variants in immunocompromised patients